Gilles Montalescot Selected Research

Duration of Therapy

2/2021	2020 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y12 Receptor Antagonists in the Asia-Pacific Region.
1/2019	Interval From Initiation of Prasugrel to Coronary Angiography in Patients With Non-ST-Segment Elevation Myocardial Infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gilles Montalescot Research Topics

Disease

166	Myocardial Infarction 04/2024 - 01/2003
137	Hemorrhage 10/2023 - 10/2002
121	ST Elevation Myocardial Infarction 04/2024 - 01/2003
102	Acute Coronary Syndrome 01/2024 - 10/2002
86	Thrombosis (Thrombus) 03/2024 - 09/2005
61	Stroke (Strokes) 02/2024 - 01/2005
30	Heart Failure 01/2023 - 01/2003
30	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 03/2004
25	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 01/2004
18	Ischemia 03/2024 - 04/2003
18	Cardiogenic Shock 01/2023 - 02/2007
15	Atrial Fibrillation 01/2024 - 01/2005
14	Infarction (Infarctions) 10/2023 - 04/2004
12	Non-ST Elevated Myocardial Infarction 12/2023 - 01/2003
12	Renal Insufficiency (Renal Failure) 01/2023 - 12/2002
9	Unstable Angina 05/2017 - 01/2003
8	Heart Arrest (Cardiac Arrest) 01/2018 - 10/2004
7	Inflammation (Inflammations) 11/2023 - 04/2003
7	Shock 01/2023 - 02/2016
7	Diabetes Mellitus 02/2022 - 10/2005
7	Hypertension (High Blood Pressure) 01/2012 - 01/2003
6	Body Weight (Weight, Body) 03/2020 - 06/2004
6	Vascular Diseases (Vascular Disease) 01/2019 - 09/2005
6	Peripheral Arterial Disease 11/2015 - 09/2005
4	Patent Foramen Ovale 01/2024 - 11/2017
4	Ischemic Stroke 09/2023 - 05/2007
4	COVID-19 01/2022 - 12/2020
4	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 10/2007
4	Chest Pain (Chest Pains) 04/2019 - 01/2006
4	Ventricular Tachycardia 01/2018 - 12/2009
3	Cardiac Arrhythmias (Arrythmia) 01/2024 - 07/2013
3	Transient Ischemic Attack 10/2023 - 01/2005
3	Necrosis 09/2023 - 09/2006
3	Chronic Renal Insufficiency 10/2020 - 05/2009
3	Coronary Disease (Coronary Heart Disease) 01/2020 - 06/2009
3	Ventricular Fibrillation 01/2020 - 12/2006
3	Acute Kidney Injury (Acute Renal Failure) 03/2019 - 04/2009
3	Atherosclerosis 12/2018 - 10/2011
3	Hematoma 01/2013 - 12/2009
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2012 - 12/2005

Drug/Important Bio-Agent (IBA)

70	Clopidogrel (Plavix)FDA Link 10/2023 - 01/2004
47	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2023 - 01/2004
41	TicagrelorIBA 10/2023 - 06/2011
40	Prasugrel Hydrochloride FDA Link 04/2024 - 10/2006
35	Glycoproteins (Glycoprotein)IBA 01/2020 - 10/2002
29	Heparin (Liquaemin)FDA LinkGeneric 12/2018 - 04/2003
28	Enoxaparin (Lovenox)FDA LinkGeneric 12/2018 - 01/2003
21	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2023 - 06/2010
15	AnticoagulantsIBA 12/2023 - 04/2007
14	omega-Chloroacetophenone (Mace)IBA 03/2024 - 07/2010
12	Biomarkers (Surrogate Marker)IBA 11/2023 - 09/2010
12	Platelet Membrane Glycoprotein IIbIBA 04/2019 - 10/2002
11	AldosteroneIBA 01/2022 - 12/2006
10	Cytochrome P-450 CYP2C19IBA 01/2020 - 01/2009
10	Abciximab (ReoPro)FDA Link 02/2012 - 03/2004
9	CreatinineIBA 03/2019 - 01/2003
9	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 03/2010 - 10/2002
8	thienopyridineIBA 01/2020 - 01/2004
8	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2020 - 01/2004
8	Eptifibatide (Integrilin)FDA Link 04/2014 - 12/2002
7	apixabanIBA 10/2023 - 06/2009
7	TroponinIBA 10/2023 - 09/2006
6	TabletsIBA 04/2024 - 01/2020
6	RivaroxabanIBA 12/2023 - 05/2017
5	Purinergic P2Y Receptor AntagonistsIBA 09/2021 - 09/2005
5	ThienopyridinesIBA 10/2014 - 01/2004
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2023 - 10/2008
4	Adenosine Diphosphate (ADP)IBA 04/2019 - 09/2006
4	Mineralocorticoid Receptor AntagonistsIBA 11/2018 - 12/2006
4	cangrelorIBA 04/2013 - 12/2009
3	PolymersIBA 03/2024 - 03/2014
3	Vitamin K FDA Link 01/2022 - 01/2018
3	ReninIBA 01/2022 - 12/2006
3	C-Reactive ProteinIBA 10/2020 - 04/2003
3	HDL CholesterolIBA 11/2019 - 08/2010
3	Morphine (MS Contin)FDA LinkGeneric 04/2019 - 01/2016
3	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 06/2010
3	Eplerenone (Inspra)FDA LinkGeneric 12/2018 - 09/2014
3	CollagenIBA 12/2018 - 10/2009
3	FibrinIBA 01/2017 - 03/2011
3	Streptokinase FDA Link 01/2016 - 12/2009
3	vasodilator-stimulated phosphoproteinIBA 11/2015 - 01/2013
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2013 - 09/2006
3	Irbesartan FDA LinkGeneric 09/2010 - 12/2005

Therapy/Procedure

135	Percutaneous Coronary Intervention 04/2024 - 10/2002
106	Therapeutics 01/2024 - 10/2002
76	Stents 03/2024 - 05/2006
20	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020 - 01/2005
10	Secondary Prevention 09/2023 - 05/2007
8	Drug-Eluting Stents 03/2024 - 01/2006
7	Thrombolytic Therapy 11/2014 - 03/2005
6	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2023 - 02/2016
5	Transcatheter Aortic Valve Replacement 12/2023 - 12/2019
5	Blood Transfusion (Blood Transfusions) 11/2023 - 04/2005
3	Bioprosthesis 12/2023 - 01/2021
3	Extracorporeal Membrane Oxygenation 01/2022 - 01/2018
3	Artificial Respiration (Mechanical Ventilation) 03/2020 - 11/2015
3	Resuscitation 03/2020 - 07/2013
3	Contraindications 01/2020 - 06/2010
3	Patient Readmission 11/2018 - 01/2012